Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ernesto López Mola"'
Publikováno v:
Biotecnología Aplicada, Vol 27, Iss 2, Pp 177-178
Externí odkaz:
https://doaj.org/article/af26c87686274c30b7cc26d4f1801438
Autor:
Yssel Mendoza-Marí, Maday Fernández-Mayola, Dania Vázquez-Blomquist, Ariana García-Ojalvo, José Suárez-Alba, Gerardo Guillén-Nieto, Ana Aguilera-Barreto, Yilian Bermúdez-Álvarez, Dayana Ugarte, Diana García del Barco-Herrera, Ernesto López-Mola, Manuel Selman-Hussein, Jorge Berlanga-Acosta
Publikováno v:
Biotecnología Aplicada, Vol 34, Iss 2, Pp 2501-2504 (2017)
Externí odkaz:
https://doaj.org/article/fb0ee148780b4b6188322ac70711a130
Autor:
Jorge Berlanga-Acosta, Ernesto López-Mola, Marianela Garcia-Siverio, Gerardo Guillen-Nieto, Pedro Lopez-Saura, Calixto Valdez-Pérez, Isabel Puentes-Madera, William Savigne-Gutierrez, Héctor Álvarez-Duarte, Norberto Miranda-Espinosa, Ana J Mir-Benítez, Diana García del Barco, Yssel Mendoza-Mari, María D Martínez-Espina, Ariana Garcia-Ojalvo, Nelvys Subiros-Martinez, Luis Herrera-Martínez
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 4, Pp 208-217 (2012)
Type 2 diabetes mellitus comprises a group of non-communicable metabolic diseases with an expanding pandemic magnitude. Diabetes predisposes to lower extremities ulceration and impairs the healing process leading to wounds chronification. Diabetes al
Externí odkaz:
https://doaj.org/article/f8ce551d27954685a708fa8f96cb519f
Publikováno v:
Integrative Molecular Medicine. 3:616-623
Autor:
Gregory S. Schultz, Luis Herrera-Martínez, Ernesto López-Mola, Jorge Berlanga-Acosta, Marianela Garcia-Siverio, Gerardo Guillén-Nieto
Publikováno v:
BioMed Research International, Vol 2013 (2013)
BioMed Research International
BioMed Research International
Type 2 diabetes mellitus is a metabolic noncommunicable disease with an expanding pandemic magnitude. Diabetes predisposes to lower extremities ulceration and impairs the healing process leading to wound chronification. Diabetes also dismantles innat
Autor:
Gerardo Guillén-Nieto, Jorge Berlanga-Acosta, Luis Herrera-Martínez, Jorge Gavilondo-Cowley, María D Castro-Santana, Pedro Lopez-Saura, Ernesto López-Mola, Tania González-López
Publikováno v:
Int Wound J
Chemotaxis, mitogenesis, motogenesis and cytoprotection are common cellular events involved in both tumourigenesis and tissue repair, which appear amplified upon growth factors exposure. Epidermal growth factor (EGF) promotes these events in epitheli
Autor:
Nelson Santiago Vispo, Gerardo Guillén, Danay Cibrian, Alberto Rodriguez, José Suárez Alba, Jorge Berlanga, Brumny Perez, Heberto Dominguez, Pedro Lopez-Saura, Luis Guevara, Diana García, Ernesto López-Mola, Alina Seralena
Publikováno v:
Clinical Science. 112:241-250
Therapies aimed at enhancing cardiomyocyte survival following myocardial injury are urgently required. As GHRP6 [GH (growth hormone)-releasing peptide 6] has been shown to stimulate GH secretion and has beneficial cardiovascular effects, the aim of t
Autor:
Luis Javier Herrera, José A Buxadó, Ernesto López Mola, Ricardo Silva, Boris Acevedo, Angel Aguilera
Publikováno v:
Journal of Commercial Biotechnology. 13:1-11
An analysis of the biotechnology development in Cuba for 20 years has been attempted in this paper. This paper deals with the evolution of the biotechnology sector from the 1980s, how it was structured and the most important scientific and technical
Autor:
Ernesto López-Mola
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 4, Pp 262-265
Diabetes mellitus has become a significant health problem throughout the world, where it constitutes the underlying cause for 84% of lower limb amputations due to recalcitrant ulcers. The Center for Genetic Engineering and Biotechnology (CIGB) at Hav
Externí odkaz:
https://doaj.org/article/e73d6dc9678e496d917957b3d1fa8b30
Autor:
Jorge Berlanga-Acosta, Dania Vázquez-Blomquist, Danay Cibrián, Yssel Mendoza, María E Ochagavía, Jamilet Miranda, José Suárez, Yolanda González-Ferrer, José M Vila, Angel Abreu, Dayana Ugarte-Moreno, Yolanda Cruz, Ivon Howland, Rosa Coro-Antich, Olga S León, Ricardo Bringas, Diana García del Barco, Karelia Cosme-Díaz, Daniel Palenzuela, Julio R Fernández, Marcelo Nazabal, Isabel Guillén, Alberto Cintado, Lidia Inés, Ernesto López-Mola, Gerardo E Guillén-Nieto
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 2, Pp 60-72
Tissue fibrosis is a leading cause of morbidity and mortality. Current treatments for conditions such as hepatic fibrosis have been unsuccessful. The growth hormone relasing peptide 6 (GHRP6) is endowed with cardioprotective actions but its antifibro
Externí odkaz:
https://doaj.org/article/6312de42be364b7fbd319f6cf96961e7